Replies to post #270650 on Amarin Corp Plc (AMRN)

[couldbebetter]

Hope your right but I still think a BO could be sooner:

1. A BP buyer needs time to ramp up in preparation for approval by EMA.
Any delay might push back what should be significant revenues on the
back end such as in 2032. (By then that could mean $3 billion for
a 6 month period. (As an example only.)

2. A BP buyer might want to handle the appeal process in a way where
they have maximum control. In other words, a BP might want to make
decisions (and not have JT make them.)

3 A BP may want to own AMRN to bring their political and lobbying
power to bear before a court decision in made. They may also want
to work with the FDA on any way they could be helpful.

4. Hopefully, a BP may want to use COVID-19 as an issue to help
their reps detail Vascepa and to increase compliance by patients.

5 Perhaps a BP may have special contacts and skills to increase
the odds for a better outcome in litigation or other possible
solutions.

6. Why would a BP wait, and risk that a hostile bidder might beat
them to the punch?